Despite moves by pharmaceutical industry regulators both here and abroad to clarify rules around use of social media, pharma companies remain wary of delving into the social networking site to promote their brand/campaigns. This reticence will not be helped by the announcement today that Bayer UK have become the first pharma company to breach the UK ABPI Code of Practice for the Pharmaceutical Industry through their use of Twitter.
What causes consumers to say “it’s not me, it’s you” and move to “unsubscribe,” “unfan,” “unlike,” or “unfollow” a brand? A new report looks at exactly that – the motivations and actions of US consumers as they terminate their relationships with brands through Email, Facebook, and Twitter.
Pfizer open an online GP surgery this week to help people quit smoking as the pharmaceutical sector start to embrace digital strategies.